Unicancer in the news
Leading cancer research organization
Tamtam found 20 recent articles about Unicancer.
- Accès aux soins, prévention, recherche... : Unicancer défend 25 propositions pour l'élection présidentielle 2027
Unicancer has released 25 propositions for the 2027 French presidential election concerning cancer care, prevention, and research, emphasizing its importance as a priority.
- Présidentielle 2027 : ce que propose Unicancer aux futurs candidats
Unicancer has outlined its proposals for the 2027 presidential election, focusing on tariff harmonization and increased healthcare professional recruitment.
- Unicancer propose une évolution du système de financement en vue de l'élection de 2027
Unicancer advocates for a financing system reform ahead of the 2027 election, supported by an independent health media offering comprehensive coverage and professional content to healthcare decision-makers.
- 5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
Clinical trial results demonstrate that shortened radiotherapy courses for early breast cancer are as safe and effective as traditional longer treatments.
- Jean-Yves Blay, président d’Unicancer : « L'augmentation spectaculaire des connaissances en cancérologie me rend optimiste »
Unicancer President Jean-Yves Blay highlights a revolution in cancer treatment through immunotherapy and AI, despite rising cases and international competition in clinical research.
- Alligator Bioscience links up with Unicancer on mitazalimab
Alligator Bioscience is partnering with Unicancer to further clinical development of its cancer immunotherapy candidate mitazalimab.
- Hypofractionated Locoregional RT in Early Breast Cancer
A French clinical trial by Unicancer proved that a shorter 3-week radiotherapy course is as safe and effective as the traditional 5-week treatment for early breast cancer patients.
- Open-innovation : Norbert Vey (IPC) nouveau président de Matwin (Unicancer, Paris)
Professor Norbert Vey has taken over the presidency of Matwin, Unicancer's innovation subsidiary, to lead oncology project development.
- La moitié des centres de lutte contre le cancer sont en déficit, quand l'argent coule à flots pour les firmes de la santé
French cancer treatment centers are struggling with financial deficits despite high profitability in the private healthcare sector.
- Unicancer table sur la réforme de la tarification de la radiothérapie pour valoriser les apports de l'IA
Unicancer is pushing for a radiotherapy pricing reform by 2027 to integrate AI-driven efficiencies and innovation funding.
- Iwona Lugowska: Unicancer Engages with Polish Delegation on National Cancer Network Development
Unicancer hosted a Polish delegation to share expertise on structuring national cancer networks and implementing health data research strategies.
- Ataraxis AI and Unicancer Partner to Validate Ataraxis™ Breast Prognostic Tool Using Global Phase III Trial Data
Ataraxis AI and Unicancer are collaborating to validate an AI breast cancer tool using data from Phase III clinical trials to improve treatment decisions.
- Pourquoi le Centre de lutte contre le cancer Jean-Perrin a décidé de s'installer au PIC à Clermont-Ferrand
The Jean-Perrin Cancer Center is integrating into the Clermont-Ferrand Collaborative Innovation Hub to foster partnerships with local businesses and research entities.
- Onco’Link : l’expérimentation nationale d’Unicancer validée pour une généralisation en droit commun
Unicancer has successfully validated a national remote monitoring model for cancer patients that coordinates hospital teams with local pharmacies to improve home-based treatment safety.
- Le Pr Steven Le Gouill, nommé vice-président au bureau d'Unicancer
Unicancer has appointed Professor Steven Le Gouill as Vice President and launched its 2025-2028 strategic plan focused on six key development axes.
- Unicancer fête les 80 ans des Centres de lutte contre le cancer et mise sur le parcours des patients traités en ville
Unicancer is expanding patient care pathways and addressing long-term cancer growth projections as it celebrates 80 years of specialized cancer centers.
- Jean-Yves Blay est réélu président d'Unicancer
Unicancer has re-elected Professor Jean-Yves Blay as its president for a new three-year term during its leadership renewal.
- Les pharmaciens d’Unicancer se mobilisent pour la recherche
Pharmacists at Unicancer have formed the PharmUniK group to lead clinical research in oncology, focusing on medication optimization, automation, and digital health.
- La stratégie d’Unicancer à l’horizon 2030
Unicancer faces financial deficits despite rising patient numbers and is prioritizing research, prevention, and home-based care in its 2030 strategy.
- La Ligue signe un accord-cadre avec Unicancer
La Ligue and Unicancer signed a 2022-2024 agreement to improve patient involvement in research and reduce inequalities in cancer treatment access.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Unicancer?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies